Cite
HARVARD Citation
Juster-Switlyk, K. et al. (2017). MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. Neurology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Juster-Switlyk, K. et al. (2017). MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. Neurology. p. . [Online].